In particular, for the first time, we wanted to demonstrate that the use of bevacizumab in the acute phase of TBI could prevent the acceleration of atherosclerosis, as Jintao Wang et al. [27] observed in their study on ApoE-deficient mice. This evidence concerns the gene APOE and atherosclerosis.